Insider Buying: Crescent Capital BDC, Inc. (NASDAQ:CCAP) CFO Buys 700 Shares of Stock

Crescent Capital BDC, Inc. (NASDAQ:CCAPGet Rating) CFO Gerhard Lombard acquired 700 shares of the business’s stock in a transaction on Monday, May 23rd. The stock was bought at an average cost of $16.84 per share, for a total transaction of $11,788.00. Following the completion of the transaction, the chief financial officer now directly owns 21,674 shares of the company’s stock, valued at $364,990.16. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink.

Gerhard Lombard also recently made the following trade(s):

  • On Thursday, May 12th, Gerhard Lombard acquired 1,000 shares of Crescent Capital BDC stock. The stock was bought at an average cost of $16.89 per share, for a total transaction of $16,890.00.

NASDAQ:CCAP traded down $0.01 during mid-day trading on Thursday, reaching $17.26. The stock had a trading volume of 71,649 shares, compared to its average volume of 109,419. The company has a market capitalization of $533.11 million, a price-to-earnings ratio of 6.40, a price-to-earnings-growth ratio of 0.86 and a beta of 0.88. Crescent Capital BDC, Inc. has a 1-year low of $16.55 and a 1-year high of $21.48. The stock’s 50 day simple moving average is $17.64 and its two-hundred day simple moving average is $18.00. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.80 and a quick ratio of 0.80.

Crescent Capital BDC (NASDAQ:CCAPGet Rating) last posted its quarterly earnings results on Wednesday, February 23rd. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. The business had revenue of $24.14 million during the quarter, compared to the consensus estimate of $24.24 million. Crescent Capital BDC had a return on equity of 7.88% and a net margin of 78.46%. Sell-side analysts anticipate that Crescent Capital BDC, Inc. will post 1.66 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 15th. Shareholders of record on Thursday, June 30th will be paid a $0.41 dividend. The ex-dividend date of this dividend is Wednesday, June 29th. This represents a $1.64 dividend on an annualized basis and a yield of 9.50%. Crescent Capital BDC’s payout ratio is currently 60.74%.

A number of hedge funds have recently modified their holdings of the business. Confluence Investment Management LLC boosted its stake in Crescent Capital BDC by 1.8% in the fourth quarter. Confluence Investment Management LLC now owns 49,066 shares of the company’s stock valued at $864,000 after acquiring an additional 885 shares during the period. Virtus ETF Advisers LLC boosted its stake in Crescent Capital BDC by 9.7% in the fourth quarter. Virtus ETF Advisers LLC now owns 18,653 shares of the company’s stock valued at $328,000 after acquiring an additional 1,651 shares during the period. Geode Capital Management LLC boosted its stake in Crescent Capital BDC by 14.8% in the third quarter. Geode Capital Management LLC now owns 12,883 shares of the company’s stock valued at $246,000 after acquiring an additional 1,661 shares during the period. UBS Group AG boosted its stake in Crescent Capital BDC by 48.2% in the first quarter. UBS Group AG now owns 6,645 shares of the company’s stock valued at $118,000 after acquiring an additional 2,160 shares during the period. Finally, Raymond James & Associates boosted its stake in Crescent Capital BDC by 8.4% in the fourth quarter. Raymond James & Associates now owns 45,471 shares of the company’s stock valued at $800,000 after acquiring an additional 3,508 shares during the period. Institutional investors own 54.76% of the company’s stock.

A number of analysts have recently issued reports on the company. Bank of America assumed coverage on Crescent Capital BDC in a research report on Monday, January 31st. They set a “buy” rating and a $19.50 target price on the stock. Zacks Investment Research lowered Crescent Capital BDC from a “hold” rating to a “sell” rating in a research report on Tuesday, April 26th. Finally, Wells Fargo & Company dropped their target price on Crescent Capital BDC from $19.50 to $18.50 and set an “overweight” rating on the stock in a research report on Monday, April 25th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, Crescent Capital BDC has a consensus rating of “Hold” and a consensus price target of $19.70.

Crescent Capital BDC Company Profile (Get Rating)

Crescent Capital BDC, Inc is a business development company. The fund focuses on originating and investing in the debt of middle market companies. It typically focuses on companies based in United States.

Further Reading

Insider Buying and Selling by Quarter for Crescent Capital BDC (NASDAQ:CCAP)

Want More Great Investing Ideas?

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.